We statistically analyzed the relationships between recurrence risk, BRAF gene mutation, gender, age at first thyroid cancer diagnosis, tumor size, extrathyroidal invasion, lymph node metastasis, and distant metastasis as well as the expression levels of PROS1, CLU, and LRG1. The gene discussed is PROS1; the disease is metastatic malignant neoplasm in the lymph nodes.